Table of Content

Table of Contents

1. Executive Summary

2. Global Real-World Evidence Solution Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Real-World Evidence Solution Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Real-World Evidence Solution Market by Component
3.3.1: Services
3.3.2: Data Sets
3.4: Global Real-World Evidence Solution Market by Application
3.4.1: Drug Development & Approvals
3.4.2: Medical Device Development & Approvals
3.4.3: Reimbursement/Coverage & Regulatory Decision Making
3.4.4: Post Market Safety & Adverse Events Monitoring
3.5: Global Real-World Evidence Solution Market by End Use
3.5.1: Healthcare Companies
3.5.2: Healthcare Payers
3.5.3: Healthcare Providers
3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Real-World Evidence Solution Market by Region
4.2: North American Real-World Evidence Solution Market
4.2.1: North American Market by Application: Drug Development & Approvals, Medical Device Development & Approvals, Reimbursement/Coverage & Regulatory Decision Making, and Post Market Safety & Adverse Events Monitoring
4.2.2: North American Market by End Use: Healthcare Companies, Healthcare Payers, Healthcare Providers, and Others
4.3: European Real-World Evidence Solution Market
4.3.1: European Market by Application: Drug Development & Approvals, Medical Device Development & Approvals, Reimbursement/Coverage & Regulatory Decision Making, and Post Market Safety & Adverse Events Monitoring
4.3.2: European Market by End Use: Healthcare Companies, Healthcare Payers, Healthcare Providers, and Others
4.4: APAC Real-World Evidence Solution Market
4.4.1: APAC Market by Application: Drug Development & Approvals, Medical Device Development & Approvals, Reimbursement/Coverage & Regulatory Decision Making, and Post Market Safety & Adverse Events Monitoring
4.4.2: APAC Market by End Use: Healthcare Companies, Healthcare Payers, Healthcare Providers, and Others
4.5: ROW Real-World Evidence Solution Market
4.5.1: ROW Market by Application: Drug Development & Approvals, Medical Device Development & Approvals, Reimbursement/Coverage & Regulatory Decision Making, and Post Market Safety & Adverse Events Monitoring
4.5.2: ROW Market by End Use: Healthcare Companies, Healthcare Payers, Healthcare Providers, and Others

5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis

6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Real-World Evidence Solution Market by Component
6.1.2: Growth Opportunities for the Global Real-World Evidence Solution Market by Application
6.1.3: Growth Opportunities for the Global Real-World Evidence Solution Market by End Use
6.1.4: Growth Opportunities for the Global Real-World Evidence Solution Market by Region
6.2: Emerging Trends in the Global Real-World Evidence Solution Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Real-World Evidence Solution Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Real-World Evidence Solution Market
6.3.4: Certification and Licensing

7. Company Profiles of Leading Players
7.1: IQVIA
7.2: IBM
7.3: PPD
7.4: Parexel
7.5: PerkinElmer
7.6: Icon Plc
7.7: Oracle
7.8: Syneos Health
7.9: Cegedim Health Data
7.10: Medpace